The first dengue vaccine candidate (CYD-TDV) to reach phase 3 clinical testing has shown moderate protection (56%) against the disease in Asian children, according to new research published in The Lancet.
Dengue is a mosquito-borne disease that infects around 390 million people each year, of whom about 96 million suffer from symptomatic infection. WHO estimates that the global burden of dengue has risen 30-fold over the past 50 years, with over half of the world’s population at risk of the disease.
There is no licensed vaccine available to treat or prevent dengue fever, and efforts to develop one have been complicated by the fact that dengue is caused by four distinct dengue viruses, and a vaccine must target all four serotypes (DENV 1–4).
This phase 3 trial took place in dengue-endemic areas across five countries in Asia, a region that accounts for over 70% of the global dengue burden. The study involved 10 275 healthy children aged 2 to 14 years who were randomly assigned to receive three injections of the CYD-TDV vaccine (6851) or a placebo (3424) at 0, 6, and 12 months, and followed for up to 2 years.
The researchers recorded 250 dengue cases more than 28 days after the third injection—117 in the vaccine group and 133 in the placebo group, demonstrating an overall protective efficacy of 56.5%.
The vaccine also showed 88.5% efficacy after 3 doses against severe disease (dengue haemorrhagic fever) which leads to hospitalisation for over half a million people (mostly children) every year, and 67% against dengue-associated hospitalisation.
The Latest on: Dengue vaccine
via Google News
The Latest on: Dengue vaccine
- Dengue Vaccine Market 2018 | Rise With a Significant and Improved Revenue Growth in Healthcare, Pharmaceuticals sector by 2023 on June 19, 2019 at 7:49 am
Jun 19, 2019 (The Expresswire via COMTEX) -- Dengue Vaccine Industry 2018 Global Market Research report 2018 covers a detailed study of the Dengue Vaccine Market size, growth, and share, trends, ... […]
- Homeopathy ‘not a cure’ for dengue on June 17, 2019 at 11:00 am
According to him, the efficacy rate cited for vaccines against dengue fever is not as high as the rate found by the department’s research, hinting at the possibility that the cited efficacy rate for ... […]
- Researchers predict 60% of globe will be at risk for dengue by 2080 on June 17, 2019 at 3:17 am
The FDA recently approved Dengvaxia (Sanofi Pasteur), but the vaccine is available only for individuals previously infected with dengue because of safety concerns. “Currently, no widely available ... […]
- Dengue Vaccine 2019 Global Trends, Market Size, Share, Status, SWOT Analysis and Forecast to 2025 on June 17, 2019 at 3:10 am
Jun 17, 2019 (Heraldkeeper via COMTEX) -- WiseGuyRerports.com Presents "Global Dengue Vaccine Market Insights, Forecast to 2025" New Document to its Studies Database The Aedes aegypti mosquito is in ... […]
- Is it Zika or dengue? New CDC guidance advises doctors to test patients for both. on June 14, 2019 at 3:00 am
Another 31 cases of dengue fever, including 21 in Miami-Dade, have been reported since January, also among travelers to other countries. There is no treatment or vaccine for Zika or dengue, both of ... […]
- Time-honoured tactics to the fore as I. Coast confronts dengue peril on June 13, 2019 at 9:01 pm
Female mosquitoes carrying the dengue virus transfer the pathogen when they tuck into a blood meal from someone. A vaccine does exist, but is not available in Ivory Coast because "it has many ... […]
- Climate change could spread dengue fever through southeast U.S. on June 11, 2019 at 1:29 pm
Dengue fever is transmitted by the Aedes mosquitoes that also ... “For infants and elderly and the infirm, they’re the ones that are going to be at risk.” There is a vaccine, but it does not work for ... […]
- Dengue Fever May Threaten More Than 6 Billion by 2080 as Climate Warms, Study Says on June 11, 2019 at 10:49 am
“Mitigation strategies must focus on dengue endemic areas, not just the risk of expansion to Western nations," he added. "Taking action now by investing in trials of novel vaccines and mosquito ... […]
- The Anatomy Of A Pandemic: A Look Back On The H1N1 Outbreak Ten Years Later on June 11, 2019 at 7:47 am
In other public health news: the Dengue fever, a potential ... (Pierre-Louis and Popovich, 6/10) CBS News: Researchers Test Vaccine They Hope Could Stem Alzheimer's Researchers at University ... […]
- Climate change could increase spread of dengue fever on June 11, 2019 at 2:22 am
While there is a dengue fever vaccine, it is ineffective for most people. Treatment for the disease focuses on ensuring that the patient gets enough fluids, which can be difficult because of severe ... […]
via Bing News